source
- Adicet Bio reports early CAR-T therapy improves lupus symptoms, plans pivotal trial as shares fallAdicet Bio said its off-the-shelf CAR-T cell therapy showed signs of efficacy in a small early-stage trial involving patients with systemic lupus erythematosus. The study reported measurable impro…
- Scynexis secures $200M+ BARDA contract for investigational antifungal SCY-247Scynexis announced a partnership with the U.S. Biomedical Advanced Research and Development Authority (BARDA) that provides more than $200 million to advance SCY-247, an experimental therapy aimed…